These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

667 related articles for article (PubMed ID: 31049932)

  • 1. Declining incidence of keratinocyte carcinoma in organ transplant recipients.
    Menzies S; O'Leary E; Callaghan G; Galligan M; Deady S; Gadallah B; Lenane P; Lally A; Houlihan DD; Morris PG; Sexton DJ; McCormick PA; Egan JJ; O'Neill JP; Conlon PJ; Moloney FJ
    Br J Dermatol; 2019 Nov; 181(5):983-991. PubMed ID: 31049932
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Risk of Second Malignancies in Solid Organ Transplant Recipients Who Develop Keratinocyte Cancers.
    Zamoiski RD; Yanik E; Gibson TM; Cahoon EK; Madeleine MM; Lynch CF; Gustafson S; Goodman MT; Skeans M; Israni AK; Engels EA; Morton LM
    Cancer Res; 2017 Aug; 77(15):4196-4203. PubMed ID: 28615224
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Risk of basal cell carcinoma in Swedish organ transplant recipients: a population-based study.
    Krynitz B; Olsson H; Lundh Rozell B; Lindelöf B; Edgren G; Smedby KE
    Br J Dermatol; 2016 Jan; 174(1):95-103. PubMed ID: 26333521
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Long-term Change in the Risk of Skin Cancer After Organ Transplantation: A Population-Based Nationwide Cohort Study.
    Rizvi SMH; Aagnes B; Holdaas H; Gude E; Boberg KM; Bjørtuft Ø; Helsing P; Leivestad T; Møller B; Gjersvik P
    JAMA Dermatol; 2017 Dec; 153(12):1270-1277. PubMed ID: 29049612
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Skin Cancer Risk in Hematopoietic Stem-Cell Transplant Recipients Compared With Background Population and Renal Transplant Recipients: A Population-Based Cohort Study.
    Omland SH; Gniadecki R; Hædersdal M; Helweg-Larsen J; Omland LH
    JAMA Dermatol; 2016 Feb; 152(2):177-83. PubMed ID: 26454261
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Spectrum of Immune-Related Conditions Associated with Risk of Keratinocyte Cancers among Elderly Adults in the United States.
    Yanik EL; Pfeiffer RM; Freedman DM; Weinstock MA; Cahoon EK; Arron ST; Chaloux M; Connolly MK; Nagarajan P; Engels EA
    Cancer Epidemiol Biomarkers Prev; 2017 Jul; 26(7):998-1007. PubMed ID: 28377416
    [No Abstract]   [Full Text] [Related]  

  • 7. Skin Cancer Development Is Strongly Associated with Actinic Keratosis in Solid Organ Transplant Recipients: A Danish Cohort Study.
    Wenande E; Togsverd-Bo K; Hastrup A; Lei U; Philipsen PA; Haedersdal M
    Dermatology; 2023; 239(3):393-402. PubMed ID: 36731451
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The presence of betapapillomavirus antibodies around transplantation predicts the development of keratinocyte carcinoma in organ transplant recipients: a cohort study.
    Genders RE; Mazlom H; Michel A; Plasmeijer EI; Quint KD; Pawlita M; van der Meijden E; Waterboer T; de Fijter H; Claas FH; Wolterbeek R; Feltkamp MCW; Bouwes Bavinck JN
    J Invest Dermatol; 2015 May; 135(5):1275-1282. PubMed ID: 25347116
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Patients with solid organ transplantation and skin cancer: determination of risk factors with emphasis in photoexposure and immunosuppressive regimen. Experience in a third level hospital].
    Rodríguez-Acosta ED; Calva-Mercado JJ; Alberú-Gómez J; Vilatoba-Chapa M; Domínguez-Cherit J
    Gac Med Mex; 2015; 151(1):20-6. PubMed ID: 25739480
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Sebaceous Carcinoma Incidence and Survival Among Solid Organ Transplant Recipients in the United States, 1987-2017.
    Sargen MR; Cahoon EK; Lynch CF; Tucker MA; Goldstein AM; Engels EA
    JAMA Dermatol; 2020 Dec; 156(12):1307-1314. PubMed ID: 33146669
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Chemoprevention of keratinocyte carcinoma and actinic keratosis in solid-organ transplant recipients: Systematic review and meta-analyses.
    Tee LY; Sultana R; Tam SYC; Oh CC
    J Am Acad Dermatol; 2021 Feb; 84(2):528-530. PubMed ID: 32387631
    [No Abstract]   [Full Text] [Related]  

  • 12. Evaluation of the Use of Capecitabine for the Treatment and Prevention of Actinic Keratoses, Squamous Cell Carcinoma, and Basal Cell Carcinoma: A Systematic Review.
    Schauder DM; Kim J; Nijhawan RI
    JAMA Dermatol; 2020 Oct; 156(10):1117-1124. PubMed ID: 32639538
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Epidemiology of basal and cutaneous squamous cell carcinoma in the U.K. 2013-15: a cohort study.
    Venables ZC; Nijsten T; Wong KF; Autier P; Broggio J; Deas A; Harwood CA; Hollestein LM; Langan SM; Morgan E; Proby CM; Rashbass J; Leigh IM
    Br J Dermatol; 2019 Sep; 181(3):474-482. PubMed ID: 30864158
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Epidemiology of keratinocyte carcinomas after organ transplantation.
    Madeleine MM; Patel NS; Plasmeijer EI; Engels EA; Bouwes Bavinck JN; Toland AE; Green AC;
    Br J Dermatol; 2017 Nov; 177(5):1208-1216. PubMed ID: 28994104
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Skin cancer risk among solid organ recipients: a nationwide cohort study in Denmark.
    Jensen AO; Svaerke C; Farkas D; Pedersen L; Kragballe K; Sørensen HT
    Acta Derm Venereol; 2010 Sep; 90(5):474-9. PubMed ID: 20814621
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Risk prediction tools for keratinocyte carcinoma after solid organ transplantation: a review of the literature.
    Lowenstein SE; Garrett G; Toland AE; Jambusaria-Pahlajani A; Asgari MM; Green A; Engels EA; Arron ST;
    Br J Dermatol; 2017 Nov; 177(5):1202-1207. PubMed ID: 28952162
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Risks of different skin tumour combinations after a first melanoma, squamous cell carcinoma and basal cell carcinoma in Dutch population-based cohorts: 1989-2009.
    van der Leest RJT; Hollestein LM; Liu L; Nijsten T; de Vries E
    J Eur Acad Dermatol Venereol; 2018 Mar; 32(3):382-389. PubMed ID: 28898461
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Polygenic Risk Scores Allow Risk Stratification for Keratinocyte Cancer in Organ-Transplant Recipients.
    Seviiri M; Law MH; Ong JS; Gharahkhani P; Nyholt DR; Olsen CM; Whiteman DC; MacGregor S
    J Invest Dermatol; 2021 Feb; 141(2):325-333.e6. PubMed ID: 32615124
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Voriconazole and the Risk of Keratinocyte Carcinomas Among Lung Transplant Recipients in the United States.
    D'Arcy ME; Pfeiffer RM; Rivera DR; Hess GP; Cahoon EK; Arron ST; Brownell I; Cowen EW; Israni AK; Triplette MA; Yanik EL; Engels EA
    JAMA Dermatol; 2020 Jul; 156(7):772-779. PubMed ID: 32401271
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Immunosuppressive level and other risk factors for basal cell carcinoma and squamous cell carcinoma in heart transplant recipients.
    Fortina AB; Piaserico S; Caforio AL; Abeni D; Alaibac M; Angelini A; Iliceto S; Peserico A
    Arch Dermatol; 2004 Sep; 140(9):1079-85. PubMed ID: 15381547
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 34.